RTA files quarterly demat confirmation certificate under SEBI Regulation 74(5)

LINCOLN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.9%1-day move

₹613.60

prior close

₹619.15

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.4-1.0——-0.9-0.9-0.4-0.9-1.3-1.7————

Up moveDown movePending

AI summary

Lincoln Pharmaceuticals' Registrar and Share Transfer Agent, MUFG Intime India, has submitted a confirmation certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The certificate confirms that securities received from depository participants for dematerialisation during the quarter were processed and reported to the depositories. Physical certificates received were mutilated and cancelled after due verification, and the names of depositories have been substituted as the registered owner in the company's register of members within the prescribed timelines.

Likely market impact

Routine quarterly compliance filing with no material impact on shareholders or stock price.